| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 47,666 | 51,306 | 54,030 | 56,390 | | Cost of Revenue | 36,700 | 35,591 | 37,748 | 40,458 | | | Gross Profit | 10,966 | 15,715 | 16,282 | 15,932 | | | Operating Expenses | | Research Development | 4,075 | 4,601 | 3,385 | 3,675 | | Selling General and Administrative | 7,017 | 10,744 | 10,302 | 8,347 | | Non Recurring | (20) | (15) |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (106) | 385 | 2,595 | 3,910 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 27,126 | (508) | 530 | 375 | | Earnings Before Interest And Taxes | 85 | (123) | 3,125 | 4,285 | | Interest Expense |
-
| (91) | 91 | 121 | | Income Before Tax | 85 | (32) | 3,034 | 4,164 | | Income Tax Expense | (280) | (211) | 1,092 | 1,023 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 365 | 179 | 1,942 | 3,141 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 365 | 179 | 1,942 | 3,141 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $365 | $179 | $1,942 | $3,141 |
|
0.01% Nasdaq 0.00%
Income Statement
